Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -3.89 |
| peg ratio | 0.37 |
| price to book ratio | 12.56 |
| price to sales ratio | 689.98 |
| enterprise value multiple | -3.64 |
| price fair value | 12.56 |
profitability ratios | |
|---|---|
| gross profit margin | -282.15% |
| operating profit margin | -16927.06% |
| pretax profit margin | -17247.54% |
| net profit margin | -16882.37% |
| return on assets | -52.6% |
| return on equity | -206.69% |
| return on capital employed | -57.98% |
liquidity ratio | |
|---|---|
| current ratio | 6.74 |
| quick ratio | 6.74 |
| cash ratio | 1.00 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 306.31 |
| cash conversion cycle | -306.31 |
| receivables turnover | 0.00 |
| payables turnover | 1.19 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 2.75 |
| long term debt to capitalization | 0.68 |
| total debt to capitalization | 0.73 |
| interest coverage | -18.58 |
| cash flow to debt ratio | -0.91 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.11 |
| cash per share | 5.76 |
| operating cash flow per share | -3.91 |
| free cash flow operating cash flow ratio | 1.31 |
| cash flow coverage ratios | -0.91 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -3.27 |
Frequently Asked Questions
Arrowhead Pharmaceuticals, Inc. (ARWR) published its most recent earnings results on 26-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)'s trailing twelve months ROE is -206.69%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Arrowhead Pharmaceuticals, Inc. (ARWR) currently has a ROA of -52.6%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ARWR reported a profit margin of -16882.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.74 in the most recent quarter. The quick ratio stood at 6.74, with a Debt/Eq ratio of 2.75.